Tissue distribution and retention drives efficacy of rapidly clearing VHL-based PROTACs

Donglu Zhang1, Bin Ma2, Peter S Dragovich2

  • 1Genentech; 1 DNA Way, South San Francisco, CA, 94080, USA. zhang.donglu@gene.com.

PubMed
Abstract

Insights

Proteolysis-targeting chimeras (PROTACs) distribute rapidly into tissues, accumulating in organs like the lung and liver. Understanding this tissue distribution is key for optimizing PROTAC therapeutic dosing and efficacy.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Oncology

Background:

  • Proteolysis-targeting chimeras (PROTACs) are emerging therapeutics with potential clinical applications.
  • However, their poor pharmacokinetic profiles and unknown tissue distribution kinetics hinder development.

Purpose of the Study:

  • To investigate the tissue distribution kinetics of a VHL-PROTAC (14C-A947) in rats and mice.
  • To elucidate in vivo clearance pathways and evaluate cell uptake/retention mechanisms.

Main Methods:

  • Quantitative whole-body autoradiography (QWBA) and tissue excision in rats and mice following IV dosing.
  • Bile duct-cannulated (BDC) rats were used to determine clearance pathways.
  • In vitro studies assessed cell uptake and retention properties.

Main Results:

  • 14C-A947 rapidly distributed into rat tissues, accumulating in the lung and liver despite fast systemic clearance.
  • Tumor growth inhibition was observed in a lung cancer model, correlating with tissue uptake/retention kinetics.
  • Solute carrier (SLC) transporters mediate hepatocyte uptake, and sustained protein degradation occurred due to prolonged cell retention.

Conclusions:

  • Plasma concentrations do not accurately reflect tissue concentrations for VHL-PROTAC efficacy.
  • Understanding PROTAC tissue uptake and retention is crucial for optimizing therapeutic dosing strategies, potentially allowing less frequent administration.

Related Concept Videos

Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.6K
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
79
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
194
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
126
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
54
Drug Distribution: Volume of Distribution01:25

Drug Distribution: Volume of Distribution

The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
5.0K